Giacomo di Nepi

Giacomo Di Nepi has extensive experience in various roles and companies within the biopharmaceutical industry. Giacomo is currently serving as a Senior Advisor at KKR & Co. Inc. and Chairman of the Board at both Peptomyc and NTC Pharma. Giacomo is also a Non Executive Director and Chairman at Zambon Biotech. Additionally, they have held positions such as Non Executive Director at GeNeuro SA and Kuros Biosciences, and CEO at Polyphor Ltd, where they successfully transformed the company into a biopharma company and led a significant IPO. Prior to this, they served as EVP and Managing Director, Europe at InterMune, where they played a key role in the launch, pricing, reimbursement, and market access of an orphan product in multiple countries. Overall, Giacomo's work experience demonstrates their expertise in the biopharmaceutical industry and their ability to drive transformation and success within organizations.

Giacomo Di Nepi has an extensive education history. Giacomo began their educational journey by attending Università Bocconi from 1972 to 1978, where they obtained a degree in Economics. Following this, in 1979-1980, they pursued an MBA degree at INSEAD. Giacomo later attended Harvard Business School from 2011 to 2012, participating in the Harvard-Novartis Senior Executive Program. In 2015, Giacomo Di Nepi furthered their education at Northwestern University - Kellogg School of Management, although the specific degree or field of study is not provided. Additionally, there is mention of Diaz, but no information is available regarding the nature of this educational institution or the period of attendance.